Pages that link to "Q28364166"

The following pages link to The mannose binding lectin gene influences the severity of chronic liver disease in cystic fibrosis (Q28364166):

Displaying 15 items.

• Genetic modifiers of liver disease in cystic fibrosis (Q30418279) (← links)
• Liver transplantation in patients with cystic fibrosis: analysis of United Network for Organ Sharing data (Q33839732) (← links)
• Common diagnostic problems in pediatric liver pathology (Q34746201) (← links)
• Chronic pancreatitis and cystic fibrosis. (Q35090222) (← links)
• The role of hepatic stellate cells and transforming growth factor-beta(1) in cystic fibrosis liver disease (Q35748097) (← links)
• Genetic influences on cystic fibrosis lung disease severity (Q36785547) (← links)
• Update on gene modifiers in cystic fibrosis (Q37277637) (← links)
• Incidence and clinical significance of elevated liver function tests in cystic fibrosis clinical trials. (Q37628124) (← links)
• HBV Viral Load and Liver Enzyme Levels May Be Associated with the Wild MBL2 AA Genotype (Q37734379) (← links)
• Disease-modifying genes and monogenic disorders: experience in cystic fibrosis (Q38233032) (← links)
• Pulmonary function in individuals who underwent liver transplantation: from the US cystic fibrosis foundation registry (Q45146722) (← links)
• Deficiency of the mannan-binding lectin pathway of complement and poor outcome in cystic fibrosis: bacterial colonization may be decisive for a relationship (Q45227453) (← links)
• Unexpected diagnosis of cystic fibrosis at liver biopsy: a report of four pediatric cases (Q59946473) (← links)
• Phase I safety, tolerability, and pharmacokinetic study of recombinant human mannan-binding lectin (Q80314024) (← links)
• Cystic fibrosis modifier genes (Q80386852) (← links)